171 related articles for article (PubMed ID: 18480495)
1. A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA.
Al-Turkmani MR; Andersson C; Alturkmani R; Katrangi W; Cluette-Brown JE; Freedman SD; Laposata M
J Lipid Res; 2008 Sep; 49(9):1946-54. PubMed ID: 18480495
[TBL] [Abstract][Full Text] [Related]
2. Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid.
Mimoun M; Coste TC; Lebacq J; Lebecque P; Wallemacq P; Leal T; Armand M
J Nutr; 2009 Dec; 139(12):2358-64. PubMed ID: 19828687
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
4. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
[TBL] [Abstract][Full Text] [Related]
5. Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism.
Andersson C; Al-Turkmani MR; Savaille JE; Alturkmani R; Katrangi W; Cluette-Brown JE; Zaman MM; Laposata M; Freedman SD
J Lipid Res; 2008 Aug; 49(8):1692-700. PubMed ID: 18441018
[TBL] [Abstract][Full Text] [Related]
6. Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in cftr-/- transgenic mice.
Zaman MM; Martin CR; Andersson C; Bhutta AQ; Cluette-Brown JE; Laposata M; Freedman SD
Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L599-606. PubMed ID: 20656894
[TBL] [Abstract][Full Text] [Related]
7. DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity.
Njoroge SW; Laposata M; Katrangi W; Seegmiller AC
J Lipid Res; 2012 Feb; 53(2):257-65. PubMed ID: 22095831
[TBL] [Abstract][Full Text] [Related]
8. Lipid peroxidation of a human hepatoma cell line (HepG2) after incorporation of linoleic acid, arachidonic acid, and docosahexaenoic acid.
Araseki M; Kobayashi H; Hosokawa M; Miyashita K
Biosci Biotechnol Biochem; 2005 Mar; 69(3):483-90. PubMed ID: 15784975
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
10. Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice.
Strandvik B; O Neal WK; Ali MA; Hammar U
Exp Biol Med (Maywood); 2018 Mar; 243(5):496-503. PubMed ID: 29513100
[TBL] [Abstract][Full Text] [Related]
11. Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms.
Wheelock CE; Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2020 Sep; 160():102156. PubMed ID: 32750662
[TBL] [Abstract][Full Text] [Related]
12. Complex Relation Between Diet and Phospholipid Fatty Acids in Children With Cystic Fibrosis.
Moukarzel S; Dyer RA; Innis SM
J Pediatr Gastroenterol Nutr; 2017 Apr; 64(4):598-604. PubMed ID: 28333826
[TBL] [Abstract][Full Text] [Related]
13. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
[TBL] [Abstract][Full Text] [Related]
14. Fatty acid metabolism in cystic fibrosis.
Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):121-9. PubMed ID: 20673710
[TBL] [Abstract][Full Text] [Related]
15. Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment.
Kain V; Halade GV
J Cell Physiol; 2019 Apr; 234(4):3910-3920. PubMed ID: 30191990
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation.
Teopompi E; Risé P; Pisi R; Buccellati C; Aiello M; Pisi G; Tripodi C; Fainardi V; Clini E; Chetta A; Rovati GE; Sala A
Front Pharmacol; 2019; 10():938. PubMed ID: 31507425
[TBL] [Abstract][Full Text] [Related]
17. Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice.
Connolly JM; Gilhooly EM; Rose DP
Nutr Cancer; 1999; 35(1):44-9. PubMed ID: 10624705
[TBL] [Abstract][Full Text] [Related]
18. Effects of essential fatty acid deficiency and supplementation with docosahexaenoic acid (DHA; 22:6n-3) on cellular fatty acid compositions and fatty acyl desaturation in a cell culture model.
Tocher DR; Dick JR
Prostaglandins Leukot Essent Fatty Acids; 2001 Jan; 64(1):11-22. PubMed ID: 11161581
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric Binding and Metabolism of Polyunsaturated Fatty Acids (PUFAs) by CYP2J2 Epoxygenase.
Arnold WR; Baylon JL; Tajkhorshid E; Das A
Biochemistry; 2016 Dec; 55(50):6969-6980. PubMed ID: 27992998
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid reduces linoleic acid induced monocyte chemoattractant protein-1 expression via PPARγ and nuclear factor-κB pathway in retinal pigment epithelial cells.
Fang IM; Yang CH; Yang CM
Mol Nutr Food Res; 2014 Oct; 58(10):2053-65. PubMed ID: 25044948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
